94
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Rearrangements of Chromosome Band 3q21 in Myeloid Leukemia

Pages 59-66 | Published online: 01 Jul 2009

  • Pintado, T., Feroo. M., San Roman, C., Mayayo, M. and Larana, J. (1985) "Clinical correlations of the 3q2l;q26 cytogenetic anomaly. A leukemic or myelodysplastic syndrome with preserved or increased platelet production and lack of response to cytotoxic drug therapy", Cancer 55, 535.
  • Jenkins, R., Tefferi, A., Solberg, L. and Dewald, G. (1989) "Acute leukemia with abnormal thrombopoiesis and inversions of chromosome 3", Cancer Genet. Cytogenet. 39,167.
  • Grigg, A., Gascoyne, R., Phillips, G. and Horsman, D. (1993) "Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the q arm of chromosome 3", Br. J. Hoematol. 83, 158.
  • Fonatsch, C., Gudat, H., Lengfelder, E., Wandt, H., Silling Engelhardt, G., Ludwig, W., Thiel, E., Freund, M., Bodenstein, H., Schwieder, G., Grüneisen, A., Aul, C., Schnittger, S., Rieder, H., Haase,. D. and Hild, F. (1994) "Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3:3)(q21:q26)", Leukemia 8, 1318.
  • Horsman, D., Gascoyne, R. and Barnett. M. (1995) "Acute leukemia with structural rearrangements of chromosome 3", Leuk. Lymph. 16, 369.
  • Secker Walker, L., Mehta, A. and Bain, B. (1995) "Abnormalities of 3q2l and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study", Br. J. Haematol. 91,490.
  • Shi, G., Weh, H.-J., Dührsen, U., Zeller, W. and Hossfeld, D. (1997) "Chromosomal abnormality inv(3)(q2lq26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies", Cancer Genet. Cytogenet. 96,58.
  • Sancho, J., Granada, L., Ribera, J., Batlle, M., Hernandez, J., Navarro, J., Fernandez, F., Milla, F. and Feliu, E. (1999) "Abnormalities in the long arm of chromosome 3 (3q) in myeloid malignancies. Study of 10 cases", Medicina Clinica 112, 499.
  • Testoni, N., Borsaru, G., Martinelli, G., Carboni, C., Ruggeri, D., Ottaviani, E., Pelliconi, S., Ricci, P., Pastano, R., Visani, G., Zaccaria, A. and Tura, S. (1999) "3q3l and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features", Haematologica 84,690.
  • Reiter, E., Greinix, H., Rabitsch, W., Keil, F., Schwarzinger, I., Jaeger,U., Lechner, K., Worel, N., Streubel, B., Fonatsch, C., Mitterbauer, G. and Kalhs, P. (2000) "Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q2lq26) or homologous translocation t(3;3) (q2l;q26)", Ann. Hematol. 79,374.
  • Bernstein, R., Pinto. M., Behr, A. and Mendelow, B. (1982) "Chromosome 3 abnormalities in acute nonlymphocytic leukemia (ANLL) with abnormal thrombopoiesis: report of three patients with a "new" inversion anomaly and a further case of homologous translocation", Blood 60, 613.
  • Bitter, M., Neilly, M., Le Beau, M., Pearson, M. and Rowley, J. (1985) "Rearrangements of chromosome 3 involving bands 3q2l and 3q26 are associated with normal at elevated platelet counts in acute nonlymphocytic leukemia", Blood 66,1362.
  • Bernstein, R., Bagg, A., Pinto, M., Lewis, D. and Mendelow, B. (1986) "Chromosome 3q2l abnormalities associated with hyper- active thrombopoiesis in acute blastic transformation of chronic myeloid leukemia", Blood 68, 652.
  • Shimizu, S., Suzukawa K., Kodera, T., Nagasawa, T., Abe, Taniwaki, M., Yagasaki, F., Tanaka, H., Fujisawa, S., Johansson, B., Ahlgren, T., Yokota, J. and Morishita, K. (2000) "Identification of breakpoint cluster regions at lp36.3 and 3q2l in hematologic malignancies with tl;3)(p36;q21)", Genes Chromosomes Cancer 27, 229.
  • Morishita, K., Parganas, E., Willman, C., Whittaker, M., Drabkin, H., Oval, J., Taetle, R., Valentine, M. and Ihle, J,(1992) "Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome and 3q26", Proc. Natl. Acad. Sci. USA 89, 3937.
  • Levy, E., Parganas, E., Morishita, K., Fichelson, S., James, L., Oscier, D., Gisselbrecht, S., Ihle, J. land Buckle, V. (1994) "DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome", Blood 83, 1348.
  • Suzukawa, K., Parganas, E., Gajjar, A., Abe, T., Takahashi, S., Tani, K., Asano, S., Asou, H., Kamada, N., Yokota, J., Morishita, K. an Ihle, J.1994) "Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26)", Blood 84, 2681.
  • Pekarsky, Y., Zabarovsky, E., Kashuba, V., Drabkin, H., Sandberg, A., Morgan, R., Rynditch, A. and Gardiner, K. (1995) "Cloning of breakpoints in 3q21 associate with hematologic malignancy", Cancer Genet. Cytogenet. 80, 1.
  • Rynditch, A., Pekarsy, Y., schnittger, S. and Gardiner, K. (1997) "Leukemia breakpoint region in 3q21 is gene rich", Gene 193, 49.
  • Wieser, R., Volz, A., Schnittger, S., Jaeger, U., Gruener, H., Meran, J., Wimmmer, K., Ziegler, A. and Fonatsch, C. (2000) "Mapping of leukaemia-associated breakpoints in chromosome band 3q21 using a newly established PAC contig". Br. J. Haematol. 110, 343.
  • Nucifora, G., Begy, C., Kobayashi, H., Roulston, D., Claxton, D., Pedersen-Bjergaard, J., Parganas, E., Ihle, J. and Rowley, J. (1994) "Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations", Proc. Natl. Acad. Sci. USA 91, 4004.
  • Peeters, P., Wlodarska, L, Baens, M., Criel, A., Selleslag, D., Hagemeijer, A., Van den Berghe, H. and Marynen, P. (1997) "Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders", Cancer Res. 57, 564.
  • Fichelson, S., Dreyfus, F., Berger, R., Melle, J., Bastard, C., Miclea, J. and Gisselbrecht, S. (1992) "EVi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region", Leukemia 6, 93.
  • Soderholm, J., Kobayashi, H., Mathieu, C., Rowley, J. and Nucifora, G. (1997) "The leukemia-associated gene MDS/EVI1 is a new type of GATA-binding transactivator", Leukemia 11,352.
  • Langabeer, S., Rogers, J., Harrison, G., Wheatley, K., Walker, H., Bain, B., Burnett, A., Goldstone, A., Linch, D. and Grimwade, D. (2001) "EVI1 expression in acute myeloid leukaemia", Br. J. Haematol. 112, 208.
  • Kreider, B., Orkin, S. and Ihle, J, (1993) "Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene", Proc. Natl. Acad. Sci. USA 90, 6454.
  • Bartholomew, C., Kilbey, A., Clark, A. and Walker, M. (1997) "The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation", Oncogene 14, 569.
  • Kilbey, A. and Bartholomew, C. (1998) "Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts", Oncogene 16, 2287.
  • Morishita, K., Parganas, E., Matsugi, T. and Ihle, J. (1992) Expression of the Evi-1 Zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor", Mol. Cell Biol. 12, 183.
  • Sitailo, S., Sood, R., Barton, K. and Nucifora, C. (1999) "Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements", Leukemia 13, 1639.
  • Kurokawa, M., Mitani, K., Yamagata, T., Takahashi, T., Izutsu, K., Ogawa, S., Moriguchi, T., Nishida, E., Yazaki, Y. and Hirai, H. (2000) "The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death", EMBO J. 19, 2958.
  • Kilbey, A., Stephens, V. and Bartholomew, C. (1999) "Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblaste", Cell Growth Differentiation 10, 601.
  • Kurokawa, M., Mitani, K., Irie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K. and Hirai, H. (1998) "The oncoprotien Evi-1 represses TGF-beta signalling by inhibiting Smad3", Nature 394, 92.
  • Louz, D., van den Broek, M., Verbakel, S., Vankan, Y., van Lom, K., Joosten, M., Meijer, D., Lowenberg, B. and Delwel, R. (2000) "Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice", Leukemia 14, 1876.
  • Khanna Gupta, A., Lopingco, M., Savinelli, T., Zibello, T., Berliner, N. and Perkins, A. (1996) "Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dc13", Oncogene 12, 563.
  • Fontenay Roupie, M., Bouscary, D., Mell, J., Viguie, F., Picard, F., Guesnu, M. and Dreyfus, F. (1997) "Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias", Hematol. Cell Ther. 39, 5.
  • Xi, Z., Russell, M., Woodward, S., Thompson, F., Wagner, L. and Taetle, R. (1997) "Expression of the Zn finger gene. EVI-1, in acute promyelocytic leukemia", Leukemia 11, 212.
  • Kazama, H., Kodera, T., Shimizu, S., Mizoguchi, H. and Morishita, K. (1999) "Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation", Cell Growth Differentiation 10, 565.
  • Russell, M., List, A., Greenberg, P., Woodward, S., Glinsmann, B., Parganas, E., Ihle, J. and Taetle, R. (1994) "Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations", Blood 84, 1243.
  • Dreyfus, F., Bouscary, D., Melle, J., Ribrag, V., Guesnu, M. and Varet, B. (1995) "Expression of the Evi-1 gene in myelodysplastic syndromes", Leukemia 9, 203.
  • Ohyashiki, J., Ohyashiki, K., Shimamoto, T., Kawakubo, K., Fujimura, T., Nakazawa, S. and Toyama, K. (1995) "Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression", Blood 85, 3713.
  • Ogawa, S., Kurokawa, M., Tanaka, T., Tanaka, K., Hangaishi, A., Mitani, K., Kamada, N., Yazaki, Y. and Hirai, H. (1996) "Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia", Leukemia 10, 788.
  • Xu, K., Wang, L., Hao, Y., Shao, Z., Meng, Q., Li, K., Chao, H., Tang, K. and Wang, L. (1999) "Evi-1 and MDSI-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia", Chin. Med. J. 112, 1112.
  • Mochizuki, N., Shimizu, S., Nagasawa, T., Tanaka, H., Taniwaki, M., Yokota, J. and Morishita, K. (2000) "A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells", Blood 96, 3209.
  • Sood, R., Talwar Trikha, A., Chakrabarti, S. and Nucifora, G. (1999) "MDS1/EVI1 enhances TGF-beta 1 signaling and strengthens its growth-inhibitory effects, but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta 1", Leukemia 13,348.
  • Wieser, R., Schreiner, U., Wollenberg, B., Neubauer, A., Fonatsch, C. and Rieder, H. (2001) "Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia", Haematologica 86, 214.
  • Wieser R., Schreiner U., Pirc-Danoewinata H., Aytekin M., Schmidt H., Rieder H. and Fonatsch C. "Interphase fluorescence in situ hybridization assay for the detection of 3q2l rearrangements in myeloid malignancies." Genes Chromosomes Cancer, in press.
  • Hamaguchi, H., Suzukawa, K., Nagata, K., Yamamoto, K., Yagasaki, F. and Morishita, K. (1997) "Establishment of a novel human myeloid leukemia cell line (HNT-34) with t(3;3)(q21;q26),t(9;22)(q34;q11) and the expression of EVI1 gene, p210 and p190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome", Br. J, Haematol. 98,399.
  • Wieser, R., Volz, A., Vinatzer, U., Gardiner, K., Jaeger, U., Mitterbauer, M., Ziegler, A. and Fonatsch, C. (2000) "Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia", Biochem. Biophys. Res. Commun. 273, 239.
  • Schnittger, S., Schoch, C., Streubel, B., Hinrichs, H., Otremba, B., Parwaresch, R. and Fonatsch, C. (1997) "A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3) (q21q26)", Genes Chromosomes Cancer 20, 292.
  • Buetzler, C., Zou, X., Popov, A. and Bruggemann, M. (1997) "Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-myc YAC", Oncogene 14, 1383.
  • Palomo, C., Zou, X., Nicholson, I., Butzler, C. and Bruggemann, M. (1999) "B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Eµ)", Cancer Res. 59, 5625.
  • Pekarsky, Y., Rynditch, A., Wieser, R., Fonatsch, C. and Gardiner, K. (1997) "Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia", Cancer Res. 57, 3914.
  • Tsai, F., Keller, G., Kuo, F., Weiss, M., Chen, J., Rosenblatt, M., Alt, F. and Orkin, S. (1994) "An early haematopoietic defect in mice lacking the transcription factor GATA-2", Nature 371, 221.
  • Jippo, T., Mizuno, H., Xu, Z., Nomura, S., Yamamoto, M. and Kitamura, Y. (1996) "Abundant expression of transcription factor GATA-2 in proliferating but not in differentiated mast cells in tissues of mice: cemonstration by in situ hybridization", Blood 87, 993.
  • Leonard, M., Brice, M., Engel, J. and Papayannopoulou, T. (1993) "Dynamics of GATA transcription factor expression during erythroid differentiation", Blood 82, 1071.
  • Labbaye, C., Valtieri, M., Barberi, T., Meccia, E., Masella, B., Pelosi, E., Condorelli, G., Testa, U. and Peschle, C. (1995) "Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis", J. Clin. Invest. 95, 2346.
  • Orlic, D., Anderson, S., Biesecker, L., Sorrentino, B. and Bodine, D. (1995) "Pluripotent hematopoietic stem cells contain high levels of mRNA for c-Kit, GATA-2, p45 NF-E2, AND c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony stimulating factor and interleukins 5 and 7", Proc. Natl. Acad. Sci. USA 92, 4601.
  • Zhou, Y., Lim, K., Onodera, K., Takahashi, S., Ohta, J., Minegishi, N., Tsai, F., Orkin, S., Yamamoto, M. and Engel, J. (1998) "Rescue of the embryonic lethal hematopoietic defect reveals a critical role for GATA-2 in urogenital development", EMBO J. 17, 6689.
  • Ohyashiki, K., Ohyashiki, J., Shimamoto, T. and Toyama, K. (1996) "Pattern of expression and their clinical implications of the GATA family, stem cell leukemia gene, and EVI1 in leukemia and myelodysplastic syndromes", Leuk. Lymph. 23, 431.
  • Robb, L. and Begley, C. (1997) "The SCL/TAL gene: roles in normal and malignant haematopoiesis", BioEssays 19, 607.
  • Dang, C. (1999) "c-myc target genes involved in cell growth, apoptosis, and metabolism", Mol. Cell Biol. 19, 1.
  • Shen, M., Harper, P. and Upadhyaya, M. (1996) "Molecular genetics of neurofibromatosis type 1 (NF1)", J. Med. Genet. 33, 2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.